MedTrace Logo

Treatment of Laryngotracheal Stenosis Using Mesenchymal Stem Cells

NCT03130374 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2019-06-07

No results posted yet for this study

Summary

The trial evaluates the safety and efficacy of the olfactory mucosa-derived mesenchymal stem cells based therapy for the patients with chronic laryngeal and tracheal stenosis

Conditions

  • Tracheal Stenosis
  • Laryngeal Stenosis
  • Mesenchymal Stem Cells

Interventions

BIOLOGICAL

Olfactory mucosa-derived mesenchymal stem cells

Olfactory mucosa-derived mesenchymal stem cells

Sponsors & Collaborators

  • Belarusian Medical Academy of Post-Graduate Education

    collaborator OTHER

  • The Republican Center for Research and Practice in Otolaryngology

    collaborator UNKNOWN

  • The Republican Research and Practical Center for Epidemiology and Microbiology

    lead OTHER

Principal Investigators

  • Andrei Y Hancharou, Dr · Head of the Laboratory for Immunology and Cellular Biotechnology, The Republican Research and Practical Center for Epidemiology and Microbiology

  • Valery L Chekan, Dr · Associate Professor of the Belarusian Medical Academy of Post-Graduate Education

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-03
Primary Completion
2019-01-04
Completion
2019-05-20

Countries

  • Belarus

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03130374 on ClinicalTrials.gov